Empowering patient care: IPC/QC solutions for cellular therapies [WEBINAR]

For more information, visit: www.miltenyibi... Standardized in-process and quality controls (IPC/QC) that enable compliance with regulatory guidelines are critical for reliable assessment of the safety and efficacy of cellular therapies throughout cell manufacturing workflows.
In this informative session we dive into the strategies to optimize point-of-care practices, focusing on analytical development and release testing:
Understand the possibilities and challenges of point-of-care practices in CGT
Dive into innovative flow cytometry-based workflows used for the analysis of critical quality attributes in cell manufacturing
Discover effective strategies to streamline IPC/QC methodologies and their impact on CGT
Learn from successful stories in point-of-care
The StainExpress Dry Antibody Cocktails are dried multicolor panels ideal for IPC/QC testing. Our tested and validated antibodies enable you to skip tedious pipetting steps, ensuring consistent and comparable results for standardized assays.
Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies offer solutions for cellular research, cell therapy, and cell manufacturing. Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, cancer, hematology, and graft engineering. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 4,700 employees in 23 countries - all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.